(Q44603647)

4 December 2017

Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism (English)

1 reference

4 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00910-7

16 March 2024

author name string

Michio Nakamura

series ordinal

1

1 reference

4 December 2017

Shohei Fuchinoue

series ordinal

2

1 reference

4 December 2017

Satoshi Teraoka

series ordinal

3

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14520624

16 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0272638603009107?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0272-6386(03)00910-7

https://api.elsevier.com/content/article/PII:S0272638603009107?httpAccept=text/plain

16 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0272-6386(03)00910-7

American Journal of Kidney Diseases

16 March 2024

published in

1 reference

4 December 2017

42

1 reference

4 December 2017

4

1 reference

4 December 2017

739-745

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

4 December 2017

1 reference

7 January 2021

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Quantitative Histological Studies on the Pathogenesis of Uremic Bone Disease*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Bone histology in incipient and advanced renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Surgical treatment of renal hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900910-7

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference